|
CN111617111A
|
|
Medicine for preventing and/or treating brain tumor and application thereof
|
|
CN110389221A
|
|
A kind of combination formula kit and its application for analyzing CD1c+ dendritic cell subgroup phenotype and function
|
|
CN110339350A
|
|
A kind of antitumor drug combination compositions and its application
|
|
CN109999190A
|
|
Application of the killed malaria parasites in the drug of preparation treating cancer
|
|
CN111434772A
|
|
Gene editing system based on CRISPR-Cas9 technology and application
|
|
AU2018420613A1
|
|
Attenuation system and use thereof
|
|
CN109312345A
|
|
A kind of promoter and its application
|
|
CN108066361A
|
|
A kind of excretion body, its preparation method and its purposes in anti-tumor drug or preparation is prepared
|
|
EP3744738A1
|
|
Chimeric antigen receptor and application thereof
|
|
CN110168093A
|
|
It is a kind of transfect cytozoon kit and its application
|
|
CN107312797A
|
|
A kind of protein regulation system and its preparation method and application
|
|
WO2018119610A1
|
|
Recombinant plasmid, recombinant plasmodium constructed therefrom and use thereof
|
|
WO2017088623A1
|
|
Anti-placenta-chondroitin-sulfate chimeric antigen receptor and application thereof
|
|
CN106977607A
|
|
A kind of Chimeric antigen receptor of anti-placenta sample chondroitin sulfate and its application
|
|
CN107427504A
|
|
Decoquinate solid dispersoid, preparation method and use
|
|
CN105753991A
|
|
Chimeric antigen receptor resistant to placenta chondroitin sulfate and application of chimeric antigen receptor
|
|
CN104906044A
|
|
Decoquinate nanometer preparation and preparing method and application thereof
|
